Skip to content

MapLight Therapeutics, Inc. MPLT Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.9%0.0pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$46.27M-8.6%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$2.1M
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$12.12M+91.0%
Alto Neuroscience logo
Alto NeuroscienceANRO
$4.06M-16.2%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$6.29M-17.4%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B+100%
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's operating lease ROU assets?
MapLight Therapeutics, Inc. (MPLT) reported operating lease ROU assets of $5.26M in Q1 2026.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.